Renal production of 20-hydroxyeicosatetraenoic acid (20-HETE), a cytoc
hrome P-450-dependent arachidonate metabolite, increases during develo
pment of hypertension in spontaneously hypertensive rats, and inhibiti
on of its production prevents hypertension. Since 20-HETE is a potent
vasoconstrictor, these findings suggest that 20-HETE may contribute to
the development of hypertension by elevating renal vascular resistanc
e. In this study we examined the direct action of 20-HETE on the affer
ent arteriole, a vascular segment crucial to the control of renal vasc
ular resistance. Rabbit afferent arterioles were microperfused at 60 m
m Hg in vitro, and 20-HETE was added to the lumen. Although 20-HETE (1
0(-10) to 10(-6) mol/L) had no effect on the diameter of nontreated af
ferent arterioles (n=6), it caused dose-dependent constriction when va
scular tone was increased with norepinephrine (0.3 mu mol/L); 20-HETE
at 10(-6) mol/L decreased diameter by 43+/-4% (n=6, P<.001). This cons
triction was abolished by disrupting the endothelium (n=5). Moreover,
pretreatment with the cyclooxygenase inhibitor indomethacin (50 mu mol
/L) or the thromboxane/endoperoxide receptor antagonist SQ29548 (1 mu
mol/L) significantly (P<.03) attenuated 20-HETE-induced constriction:
20-HETE at 10(-6) mol/L constricted norepinephrine-treated afferent ar
terioles by 28+/-3% (n=6) and 25+/-4% (n=5), respectively. These resul
ts demonstrate that an increase in afferent arteriolar tone is require
d for the vasoconstrictor action of 20-HETE, which is partly mediated
by the endothelial cyclooxygenase pathway. Thus, increased production
of 20-HETE in the kidney and increase in afferent arteriolar tone, bot
h of which often precede the development of hypertension, may synergis
tically contribute to the development of hypertension by elevating ren
al vascular resistance.